This biotech startup is Y Combinator's latest unicorn after raising $275M

With a massive new influx of financing, South Boston-based Ginkgo Bioworks has joined an exclusive club: privately held life sciences companies in the state worth over $1 billion. It emerged from Y Combinator as part of its Summer 2014 batch as the first biotech backed by the Mountain View-based startup program. YC has worked with more than a dozen companies that are valued at $1 billion or more, including Dropbox, Stripe and Airbnb. Ginkgo, which makes microbes that are u sed in a wide range of…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news